about
Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite.Safety of high-dose-rate stereotactic body radiotherapy.A model of photon cell killing based on the spatio-temporal clustering of DNA damage in higher order chromatin structures.Late-responding normal tissue cells benefit from high-precision radiotherapy with prolonged fraction delivery times via enhanced autophagy.Radiobiological response to ultra-short pulsed megavoltage electron beams of ultra-high pulse dose rate.Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amountStereotactic body radiation therapy (SBRT) for lung malignancies: preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per minute.Advances and future of Radiation Oncology.Biology of high single doses of IORT: RBE, 5 R's, and other biological aspectsPreclinical animal research on therapy dosimetry with dual isotopes.The application of the linear quadratic model to compensate the effects of prolonged fraction delivery time on a Balb/C breast adenocarcinoma tumor: An in vivo study.High dose rate and flattening filter free irradiation can be safely implemented in clinical practice.Early effects comparison of X-rays delivered at high-dose-rate pulses by a plasma focus device and at low dose rate on human tumour cells.Impact of flattening-filter-free radiation on the clonogenic survival of astrocytic cell lines.Flattening filter-free accelerators: a report from the AAPM Therapy Emerging Technology Assessment Work Group.Comparable cell survival between high dose rate flattening filter free and conventional dose rate irradiation.Optimization of temporal dose modulation: comparison of theory and experiment.Apparent absence of a proton beam dose rate effect and possible differences in RBE between Bragg peak and plateau.Using state variables to model the response of tumour cells to radiation and heat: a novel multi-hit-repair approach.DNA damage enhancement from gold nanoparticles for clinical MV photon beams.Estimation of cell response in fractionation radiotherapy using different methods derived from linear quadratic model.Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?A Comment on Qi et al.: An Estimation of Radiobiological Parameters for Head-and-Neck and the Clinical Implications. Cancers, 2012, 4, 566-580.Optimal weekly scheduling in fractionated radiotherapy: effect of an upper bound on the dose fraction size.Optimal number and sizes of the doses in fractionated radiotherapy according to the LQ model.Thermal limits on MV x-ray production by bremsstrahlung targets in the context of novel linear accelerators.Dependence of micronuclei assay on the depth of absorbed dose.Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice.Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device.Altered fractionation radiotherapy with or without chemotherapy in the treatment of head and neck cancer: a network meta-analysis
P2860
Q34211377-176D773A-7B37-44A6-A11A-DF609E365C2EQ35036789-F768B62E-0CE6-4D0D-873D-6FE82593683EQ35083280-9649F4E7-2DB7-4DFB-A06C-EFC74C72741CQ35171994-63C6E98E-BA51-4751-B83E-26193FED29F6Q35629381-0F6817F0-B19A-43D8-ABB1-CB4257C8FC50Q35675498-529E6668-91D2-4E39-A6BE-730973159585Q37348287-60DA8D3D-5549-46B6-8C27-B3139992A19BQ37392490-106F5CC3-9F3E-4C0E-AEAD-7180A4352C54Q37597275-C2E90D1D-2BDB-4A50-A2A6-D7DF0DB5CAE8Q37864157-7401CA1E-99D5-47A7-BC61-59E40B34AB45Q38814882-50948DB8-C485-49A0-96D0-E4E7B139DD1AQ38857560-26191201-9BEE-42A0-8D72-3943AC9326DBQ38885963-F8182EC8-6A44-48E4-9130-0EBBD7D3D946Q38900782-855D0A38-A856-497C-AC68-DCF9A3D6EEA4Q38992461-3DDC22D2-E625-4226-B452-F1D04E63098AQ39249483-41657A65-C3C8-405B-B0DA-D7553FB709DAQ39320705-A23EE50F-9503-41A5-A3C7-5BDF541E9567Q39629954-20C36140-EFB5-4AE2-82E0-ADA0F5B7DCC9Q41771762-0AF9E7DD-FC71-402C-959C-94B28DF35615Q42011166-6598E266-137D-45A0-98CC-EE8A6EE9D2BEQ42183152-C8954598-F8F2-49E2-9600-CAE578D0C889Q42841450-410A2CCA-932C-4941-AE78-1507575B27B1Q43075570-84E6E7A9-88D7-48F8-96E2-C86F69D88D91Q47439697-565C4113-3D4D-498C-9C25-15C3062FEE16Q47560995-4EC3010F-E121-41ED-A065-673E6E3BD1E8Q47855330-7B2287F7-BB24-49A1-879F-86EE0F718439Q48563397-C6A805B3-4E5A-48E6-A513-4F0F0680FC3AQ53034307-12953985-CC3C-46B2-BE34-7E07BC222A3CQ55454249-51865660-03D3-4A9F-A4C1-38C509061AC3Q58764983-BF94EEC6-543C-4CD8-95EE-9D884D24E5E1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dose-rate effects in external beam radiotherapy redux.
@en
Dose-rate effects in external beam radiotherapy redux.
@nl
type
label
Dose-rate effects in external beam radiotherapy redux.
@en
Dose-rate effects in external beam radiotherapy redux.
@nl
prefLabel
Dose-rate effects in external beam radiotherapy redux.
@en
Dose-rate effects in external beam radiotherapy redux.
@nl
P2093
P1476
Dose-rate effects in external beam radiotherapy redux.
@en
P2093
C Clifton Ling
Ellen Yorke
Leo E Gerweck
P304
P356
10.1016/J.RADONC.2010.03.014
P50
P577
2010-04-01T00:00:00Z